Burden of vaccine-preventable diseases in adults (50+) in the United States: a retrospective claims analysis by Maximilian Hartmann, Nathalie Servotte, Emmanuel Aris, T. Mark Doherty, Ahmed Salem, Ekkehard Beck

Connect to this object online.

The potential public health impact of adolescent 4CMenB vaccination on Neisseria gonorrhoeae infection in England: a modelling study by Katharine J. Looker, Ross Booton, Najida Begum, Ekkehard Beck, Jing Shen, Katherine M. E. Turner, Hannah Christensen

Connect to this object online.

Substantial reduction in the clinical and economic burden of disease following variant-adapted mRNA COVID-19 vaccines in immunocompromised patients in France by Amy Lee, Benjamin Davido, Ekkehard Beck, Clarisse Demont, Keya Joshi, Michele Kohli, Michael Maschio, Mathieu Uhart, Nadia El Mouaddin

Connect to this object online.

Care pathways in invasive meningococcal disease: a retrospective analysis of the French national public health insurance database by Catherine Weil-Olivier, Muhamed-Kheir Taha, Stéphane Bouée, Corinne Emery, Véronique Loncle-Provot, Gaëlle Nachbaur, Ekkehard Beck, Céline Pribil

Connect to this object online.

Cost-benefit analysis of the National Immunization Program in Spain by Alberto Pérez, María Fernández Prada, Natalia Cassinello, Laura Amanda Vallejo-Aparicio, Andrea García, Almudena González, Ana Durán, Néboa Zozaya, Irene Fernández, Mathilde Daheron, Álvaro Hidalgo, Ekkehard Beck, Antonio García Ruiz

Connect to this object online.

Country score tool to assess readiness and guide evidence generation of immunization programs in aging adults in Europe by Thi Hao Pham, Thi Hao Pham, Ekkehard Beck, Maarten J. Postma, Maarten J. Postma, Maarten J. Postma, Bertalan Németh, Tamás Ágh, Chiara de Waure, David M. Salisbury, Nynke Nutma, Jurjen van der Schans, Jurjen van der Schans

Connect to this object online.